Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/28/2025

Blood Pressure Management for Elevated Blood Pressure Levels

Rationale for Combination Therapy

  • The European Society of Cardiology recommends initiating combination therapy with a RAS blocker (ACE inhibitor or ARB) and a dihydropyridine calcium channel blocker for patients with confirmed hypertension ≥140/90 mmHg, as it achieves faster blood pressure control and targets multiple pathophysiological pathways simultaneously 1, 2
  • Combination therapy is the recommended initial approach for confirmed hypertension ≥140/90 mmHg because it achieves faster blood pressure control and targets multiple pathophysiological pathways simultaneously, with preferred combinations being a RAS blocker (ACE inhibitor or ARB) with a dihydropyridine calcium channel blocker, according to the European Society of Cardiology 1, 2

Treatment Goals and Monitoring

  • The target blood pressure is 120-129 mmHg systolic (if well tolerated), with diastolic <90 mmHg, as recommended by the European Society of Cardiology 1, 2
  • Initiate therapy promptly, without delaying treatment for lifestyle modifications alone at this blood pressure level, as recommended by the European Society of Cardiology 1, 2
  • Reassess monthly until target blood pressure is achieved, and once controlled, follow-up every 3-5 months, according to the American Heart Association 3

Important Clinical Considerations

  • Contraindications to ACE inhibitors (lisinopril) include pregnancy or women of childbearing potential without contraception, bilateral renal artery stenosis, and history of angioedema, as stated by the British Medical Journal 4, 5
  • Relative cautions for using ACE inhibitors include significant renal impairment (eGFR <30 mL/min) and severe aortic stenosis, according to the British Medical Journal 4, 5
  • If blood pressure remains uncontrolled on maximum doses of amlodipine + lisinopril, add a thiazide-like diuretic (indapamide or chlorthalidone) as third-line therapy, as recommended by the European Society of Cardiology 1, 2, 6

Common Pitfalls to Avoid

  • Do not use monotherapy for blood pressure this elevated - it will delay achieving target and increase cardiovascular risk, as stated by the European Society of Cardiology 1, 2
  • Do not combine two RAS blockers (ACE inhibitor + ARB) - this is explicitly not recommended by the European Society of Cardiology 1, 2
  • Do not withhold treatment waiting for lifestyle modifications - at this blood pressure level, immediate pharmacological intervention is required, according to the European Society of Cardiology 1, 2
  • Monitor for hypotension in the first few weeks, especially if the patient is volume depleted, as recommended by the European Society of Cardiology 7, 8
  • Check renal function and potassium within 1-2 weeks of starting ACE inhibitor therapy, according to the British Medical Journal 4